Dr. Koray Erdoğan’s U.S.-Patented KE-Bot Sets a New Benchmark in Hair Transplantation

Hair transplantation has emerged as one of the most rapidly advancing and widely practiced fields within aesthetic medicine ...

Does Genmab’s Claude-Powered R&D Push Reshape the Bull Case for Genmab (CPSE:GMAB)?

On 7 January 2026, Genmab A/S announced a partnership with Anthropic to deploy custom Claude-powered AI agents to accelerate ...
TMCnet

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large …

Based on the topline results from the EPCORE ® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss ...
Le Lézard

AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large …

AbbVie today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging ...

2026’s biggest beauty trends: LED devices, salmon DNA injectables and the return of bronzer

New product launches will focus on repairing and protecting the skin while simultaneously making it look and feel good. An ...

Winter Hormone Drift: Why Your Menstrual Cycle Feels Different In Colder Months

Noticing menstrual cycle changes in winter? Doctors explain why ovulation and hormone balance often shift during colder ...
Le Lézard

Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque

Organon , a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) has approved ...